Stock CLDI CALIDI BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Calidi Biotherapeutics, Inc.

Equities

CLDI

US3207031010

Market Closed - Nyse
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
0.22 USD +15.79% Intraday chart for Calidi Biotherapeutics, Inc. -3.85% -85.43%
Jun. 03 Calidi Biotherapeutics Presents Cld-101 Phase 1 Trial Update and Preclinical Data Highlighting Rtnova and Cld-201 At 2024 Asco Annual Meeting CI
May. 16 Calidi Biotherapeutics, Inc. Announces Resignation of David Lapre as Director CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CALIDI BIOTHERAPEUTICS, INC. Stock Calidi Biotherapeutics, Inc.
 10.77M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 24.82B -
ARGENX SE Stock argenx SE
 22.48B -
GENMAB A/S Stock Genmab A/S
 18.32B
  1. Stock Market
  2. Equities
  3. CLDI Stock
  4. Charts Calidi Biotherapeutics, Inc.
  5. Sector Chart